Kits Eyecare Ltd. (TSX:KITS)
Canada flag Canada · Delayed Price · Currency is CAD
14.25
+0.18 (1.28%)
May 1, 2026, 4:00 PM EST

Kits Eyecare Earnings Call Transcripts

Fiscal Year 2025

  • Q4 and FY 2025 saw record revenue and profitability, driven by strong growth in glasses, contact lenses, and AI glasses, with expanding gross margins and high repeat customer rates. The company remains debt-free, well-capitalized, and is guiding for continued growth in 2026.

  • Record Q3 revenue grew 25% year-over-year, with strong Canadian performance and 12th straight positive Adjusted EBITDA quarter. KITS branded contact lenses and premium lenses drove high-margin growth, while U.S. investment is set to resume as market conditions stabilize.

  • Q2 2025 saw record revenue and customer growth, with strong gains in glasses and premium lens upgrades, improved gross margin, and continued positive adjusted EBITDA. Guidance for Q3 projects further revenue and margin expansion, supported by technology innovation and efficient capital management.

  • AGM 2025

    The meeting confirmed quorum, presented financial statements, and re-elected all six director nominees. MNP LLP was reappointed as auditor, and all resolutions were approved by shareholders. Voting results will be published on SEDAR+ and the company website.

  • Q1 saw record revenue and gross profit growth, with all segments expanding over 30% year-over-year and strong repeat customer metrics. Guidance for Q2 remains robust, with continued investment in customer acquisition and operational efficiency, and inventory normalization expected by Q3.

  • A vertically integrated, online eyewear provider is leveraging automation, data, and creative marketing to disrupt a $70 billion market, achieving 35% organic growth and strong customer retention. With scalable infrastructure and a focus on premium segments, it targets $500 million revenue and 15–20% EBITDA in five years.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Powered by